Efficacy, safety and pharmacokinetics of biosimilars of anti-tumor necrosis factor-α agents in rheumatic diseases; A systematic review and meta-analysis.
about
CT-P13 in the treatment of rheumatoid arthritis.Infliximab Biosimilars: A Promising but Unusual Treatment for Mycobacterial Immune Reconstitution Inflammatory Syndrome in Human Immunodeficiency Virus-Infected Patients.Single-nucleotide polymorphisms in cachexia-related genes: Can they optimize the treatment of cancer cachexia?Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients-authors' reply.Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune Disease.Editorial: CT-P13, a biosimilar of anti-tumour necrosis factor-alpha agent (infliximab), in inflammatory bowel diseases - authors' reply.The Effect of TNF and VEGF on the Properties of Ea.hy926 Endothelial Cells in a Model of Multi-Cellular Spheroids.
P2860
Q38676104-2E8F0C02-BBFF-4118-9BD8-88586776A750Q41694401-FFED6A49-E865-497A-87A0-311E456995F5Q42336582-C61D7B4A-9B59-4509-8B49-45A0AD901852Q47662817-7A9DF730-DED8-4A0D-A196-BDFD5AF90544Q47935082-D479AB80-04A4-4EDF-A736-7D0E7BF3BF20Q48267381-6409F8EB-F075-4D7D-8695-40D9F3C62FFCQ55361323-F29C5602-1101-43EC-92E5-1D80365CA426
P2860
Efficacy, safety and pharmacokinetics of biosimilars of anti-tumor necrosis factor-α agents in rheumatic diseases; A systematic review and meta-analysis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Efficacy, safety and pharmacok ...... atic review and meta-analysis.
@en
Efficacy, safety and pharmacok ...... atic review and meta-analysis.
@nl
type
label
Efficacy, safety and pharmacok ...... atic review and meta-analysis.
@en
Efficacy, safety and pharmacok ...... atic review and meta-analysis.
@nl
prefLabel
Efficacy, safety and pharmacok ...... atic review and meta-analysis.
@en
Efficacy, safety and pharmacok ...... atic review and meta-analysis.
@nl
P2093
P1476
Efficacy, safety and pharmacok ...... atic review and meta-analysis.
@en
P2093
Akihiro Yamada
Dejan Micic
Fukiko Komaki
Praneeth Kudaravalli
Yuga Komaki
P356
10.1016/J.JAUT.2017.02.003
P577
2017-02-13T00:00:00Z